[HTML][HTML] Molecular pathogenesis, immunopathogenesis and novel therapeutic strategy against COVID-19

SK Chatterjee, S Saha, MNM Munoz - Frontiers in molecular …, 2020 - frontiersin.org
The coronavirus disease 2019 (COVID-19), is a highly contagious transmittable disease
caused by a recently discovered coronavirus, pathogenic SARS-CoV-2. Followed by the …

SARS-CoV-2-specific immune response and the pathogenesis of COVID-19

E Gusev, A Sarapultsev, L Solomatina… - International journal of …, 2022 - mdpi.com
The review aims to consolidate research findings on the molecular mechanisms and
virulence and pathogenicity characteristics of coronavirus disease (COVID-19) causative …

An updated insight into the molecular pathogenesis, secondary complications and potential therapeutics of COVID-19 pandemic

S Jamwal, A Gautam, J Elsworth, M Kumar, R Chawla… - Life sciences, 2020 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) is an unprecedented disease caused by
highly pathogenic SARS-CoV-2 and characterized by extreme respiratory deterrence …

Virology, pathogenesis, diagnosis and in-line treatment of COVID-19

PK Samudrala, P Kumar, K Choudhary… - European journal of …, 2020 - Elsevier
Abstract SARS-CoV-2, a newly emerged pathogen in December 2019, marked as one of the
highly pathogenic Coronavirus, and altogether this is the third coronavirus attack that …

The expression level of angiotensin-converting enzyme 2 determines the severity of COVID-19: lung and heart tissue as targets

MMN Babadaei, A Hasan, SH Bloukh… - Journal of …, 2021 - Taylor & Francis
Researchers have reported some useful information about the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) leading to CoV disease 2019 (COVID-19). Several …

The pathophysiology, diagnosis and treatment of corona virus disease 2019 (COVID-19)

SK Das - Indian Journal of Clinical Biochemistry, 2020 - Springer
Since the beginning of this century, beta coronaviruses (CoV) have caused three zoonotic
outbreaks. However, little is currently known about the biology of the newly emerged SARS …

The molecular basis of COVID-19 pathogenesis, conventional and nanomedicine therapy

S Kouhpayeh, L Shariati, M Boshtam… - International journal of …, 2021 - mdpi.com
In late 2019, a new member of the Coronaviridae family, officially designated as “severe
acute respiratory syndrome coronavirus 2”(SARS-CoV-2), emerged and spread rapidly. The …

The novel insight of SARS-CoV-2 molecular biology and pathogenesis and therapeutic options

A Asghari, M Naseri, H Safari, E Saboory… - DNA and Cell …, 2020 - liebertpub.com
On December 31, 2019, a novel coronavirus, being the third highly infective CoV and named
as coronavirus disease 2019 (COVID-19) in the city of Wuhan, was announced by the World …

Current understanding of novel coronavirus: molecular pathogenesis, diagnosis, and treatment approaches

NK Jha, M Jeyaraman, M Rachamalla, S Ojha, K Dua… - Immuno, 2021 - mdpi.com
An outbreak of “Pneumonia of Unknown Etiology” occurred in Wuhan, China, in late
December 2019. Later, the agent factor was identified and coined as severe acute …

[HTML][HTML] Pathophysiology and clinical management of coronavirus disease (COVID-19): a mini-review

Y Zhu, L Sharma, D Chang - Frontiers in Immunology, 2023 - frontiersin.org
An unprecedented global pandemic caused by a novel coronavirus named SARS-CoV-2
has created a severe healthcare threat and become one of the biggest challenges to human …